Question 1

What EU grants are available for the Biotechnology sector?

Accepted Answer

The European Commission offers a wide range of funding opportunities specifically designed for the Biotechnology sector. These include grants through Horizon Europe (the EU's flagship research and innovation programme with a budget of €95.5 billion), the European Innovation Council (EIC) which provides funding for breakthrough innovations, and various sector-specific initiatives. Funding types range from Research and Innovation Actions (RIA) with 100% funding rates, to Innovation Actions (IA) with 70% funding for companies, and Coordination and Support Actions (CSA) for networking and coordination activities. Our database helps you find grants that match your organization's specific needs, project stage, and funding requirements.

Question 2

How do I apply for Biotechnology grants from the EU?

Accepted Answer

Applying for EU grants in the Biotechnology sector involves several key steps. First, use Grantalist to identify suitable open calls that match your project idea and organization type. Next, carefully review the call documentation, including eligibility criteria, evaluation criteria, and the work programme. Most EU grants require you to form a consortium with partners from at least 3 different EU member states or associated countries. Once ready, you'll submit your proposal through the EU Funding & Tenders Portal, which includes a detailed description of your project, work packages, budget breakdown, and impact assessment. The evaluation process typically takes 3-5 months, after which successful applicants enter grant agreement preparation. We recommend starting your application at least 2-3 months before the deadline.

Question 3

What is the typical funding amount for Biotechnology EU grants?

Accepted Answer

EU grants for the Biotechnology sector offer diverse funding levels depending on the programme and action type. Small-scale grants through programmes like EIC Accelerator can start from €500,000 up to €2.5 million in grant funding, plus up to €15 million in equity investment. Collaborative research projects under Horizon Europe typically range from €3 million to €10 million for standard projects, while some large-scale flagship initiatives can exceed €20 million. SMEs and startups often benefit from higher funding rates (up to 70% for Innovation Actions compared to large companies) and access to specialized instruments. The exact amount depends on the specific call topic, project scope, consortium size, and type of activities proposed.

Question 4

Who is eligible for Biotechnology EU grants?

Accepted Answer

Eligibility for Biotechnology EU grants extends to a wide range of organizations. Legal entities from EU member states and associated countries (including the UK for some programmes, Norway, Switzerland, and others) are typically eligible. This includes universities and research institutions, large enterprises and multinational corporations, small and medium-sized enterprises (SMEs) with fewer than 250 employees, startups and scale-ups, public bodies and NGOs, and international organizations. Some calls specifically target certain organization types, such as SME-only calls or academic-focused research grants. Third-country participation is possible in many programmes, though often without EU funding.

EU Grants for Biotechnology

Living labs to enhance soil health in Continental, Black Sea, Pannonian and Steppic biogeographical regions

Open topic: Innovative solutions for the European Water Resilience Strategy

Prevention and management of chronic non-communicable diseases in children and young people (GACD)

Innovative healthcare interventions for non-communicable diseases

Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Addressing disabilities through the life course to support independent living and inclusion

Clinical trials for advancing innovative interventions for neurodegenerative diseases

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Portable and versatile Point-of-care diagnostics

Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

Development of innovative antimicrobials against pathogens resistant to antimicrobials

Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

Development of cell-free protein synthesis platforms for discovery and/or production of biologicals

European Partnership for Pandemic Preparedness (Phase 2)

Data-driven circular economy for e-mobility ecosystem (2ZERO Partnership)

Autonomous vessels in short sea shipping and inland waterways

Prospective evaluation of nuclear power potential for shipping (ZEWT Partnership)

Assessing the effect of airport operations on air quality and noise in nearby communities

Onboard renewable energy solutions and energy saving measures to reduce the fuel consumption of ships by at least 55% (ZEWT Partnership)

Novel approaches towards next-generation battery concepts, leveraging the enabling role of innovative advanced materials (BATT4EU and IAM4EU Partnerships)

Fire prevention and mitigation for EVs in confined areas (2ZERO Partnership)

MSCA Staff Exchanges 2027

Open topic on reinvigorating and shielding European democracy

Increasing knowledge flows to practice within AKIS via EU thematic knowledge hubs

Fostering generational renewal in agriculture via EU advisory network

Improving analytical capacity for sustainable competitiveness of the agricultural sector

Strengthening the resilience of European farmers through improved capacity in coping with risks and crises

AI supporting informed advice for farmers and foresters to improve competitiveness and sustainability

Frequently Asked Questions About Biotechnology EU Grants